low
qualiti
high
rate
antimicrobi
resist
part
relat
diagnost
uncertainti
result
inappropri
antimicrobi
therapi
need
strengthen
microbiolog
capac
improv
patient
care
surveil
global
health
secur
capac
strengthen
requir
recognit
import
microbiolog
across
level
health
care
develop
skill
scientist
best
serv
standardis
undergradu
train
program
specialist
postgradu
train
microbiolog
mentor
success
method
improv
knowledg
allow
develop
essenti
relationship
necessari
effect
chang
implement
contextu
appropri
standard
oper
procedur
intern
standard
suscept
test
qualiti
control
extern
qualiti
assur
requir
mass
clinician
understand
necessari
pre
postanalyt
qualiti
systemat
collect
qualiti
specimen
essenti
develop
nation
region
surveil
system
increas
donor
support
includ
provis
purchas
maintain
essenti
equip
consum
requir
bacteriophag
therapi
offer
new
option
age
antibiot
resist
session
discuss
long
histori
recent
experi
phage
therapi
examin
advantag
disadvantag
therapeut
approach
recent
experi
confirm
use
safe
includ
high
dose
intraven
critic
ill
also
highlight
import
unknown
around
dose
schedul
combin
therapi
outlin
question
remain
open
centuri
clinic
use
discuss
immedi
option
prioriti
research
develop
depart
microbiolog
pathlab
laboratori
tauranga
new
zealand
last
twenti
year
seen
flood
new
microbiolog
assay
adopt
clinic
diagnost
microbiolog
laboratori
multiplex
pcr
gene
probe
fish
etc
gener
assay
addit
oppos
replac
tradit
culturebas
microbiolog
test
given
meet
budget
time
close
look
clinic
valu
tradit
microbiolog
test
provid
patient
profess
maximis
clinic
valu
minimis
clinic
harm
process
everyth
arriv
laboratori
specif
sampl
type
provid
littl
clinic
valu
patient
process
sampl
insuffici
clinic
detail
microbiolog
laboratori
influenc
antimicrobi
prescrib
habit
clinician
question
discuss
detail
highlight
increasingli
import
role
clinic
microbiologist
microbiolog
scientist
play
implement
effect
diagnost
antimicrobi
stewardship
background
qualiti
assur
qa
test
import
abil
certain
result
provid
patient
accur
definit
test
agent
biosecur
concern
includ
secur
sensit
biolog
agent
ssba
tier
agent
anthrax
ebolaviru
influenza
hpai
sar
smallpox
plagu
tier
agent
swine
fever
botul
tularaemia
yellow
fever
etc
test
qa
limit
need
contain
level
difficulti
access
reagent
due
seriou
public
health
consequ
organ
releas
increas
regul
method
provid
qa
biosecur
qualiti
assur
program
bsqap
form
ssba
regulatori
scheme
control
select
agent
establish
program
address
uniqu
problem
ssba
utilis
novel
method
qa
includ
subgenom
noninfecti
molecular
target
onlin
elearn
recent
whole
genom
sequenc
wg
program
assess
new
technolog
discuss
emerg
technolog
multiplex
biofir
system
wg
continu
emerg
novel
threat
ebolaviru
hpai
mean
laboratori
need
rapid
accur
qa
support
test
introduc
nation
refer
laboratori
respons
emerg
threat
often
lack
prior
qa
experi
appropri
reagent
address
systemat
regulatori
prepared
phln
modul
earli
government
engag
novel
methodolog
high
level
engag
commonwealth
afp
expertis
assist
success
public
health
respons
